AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TruSpine Technologies Plc

Management Reports Jun 23, 2021

10307_rns_2021-06-23_ac9560e8-2f43-485a-a924-f74d8fa5ebb1.html

Management Reports

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7666C

TruSpine Technologies PLC

23 June 2021

TruSpine Technologies plc

("TruSpine" or the "Company")

Appointment of Vice President of Sales and Marketing

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market is pleased to announce the appointment of Anthony Swoboda as Vice President of Sales and Marketing for North America.

Anthony brings nearly 20 years of experience working in International Sales and Marketing to TruSpine; as well as a BBA and MBA in Business from the University of Memphis. Most recently, he was Director of Sales for Consensus Orthopaedics where he formalised the go-to-market strategy for their TracPatch Knee and Spine product, which required the recruitment of over 50 orthopaedic joint and spine distributors.

"With an already well-established network in this field, Anthony is an extremely strong addition to the team, joining TruSpine at the perfect time in our continuing growth," says Ian Roberts, CEO of TruSpine Technlogies "He will be overseeing the growth and development of our distribution network across North America at an exciting moment in the Company's history."

The Directors of the Company are responsible for the release of this announcement.

Enquiries:

Truspine Technologies Plc Tel: +44 (0)20 3638 5025
Ian Roberts, CEO
via [email protected]
WH Ireland (Broker) Tel: +44 (0)20 7220 1666
Adam Pollock
Walbrook PR (Financial PR & IR) Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001
Anna Dunphy [email protected]

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXEAXKAALKFEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.